| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.44M | - | |
| Other | 56.4K | $9.02M | - | |
| Other | 22.4K | $3.58M | - | |
| Other | 16.2K | $2.59M | -8,433 | |
| Other | 13.3K | $2.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 2,274 | $118.37 | $269,167.24 | -0.4% | +1.4% | +15.9% | |
| Feb 3, 2025 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE | 1,045 | $150.81 | $157,594.39 | -14.2% | -26.9% | -7.4% | |
| Jan 31, 2025 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 1,740 | $152.89 | $266,024.95 | -4.5% | -29.8% | -10.4% | |
| Jan 31, 2025 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 1,457 | $152.80 | $222,636.16 | -4.3% | -29.8% | -10.4% | |
| Jan 31, 2025 | Onyia Jude51 | Chief Scientific Officer | Sale+OE | 126 | $152.97 | $19,273.98 | -0.8% | -29.8% | -10.4% | |
| Jan 31, 2025 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 1,250 | $152.91 | $191,133.00 | -3.0% | -29.8% | -10.4% | |
| Jan 31, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 1,541 | $152.87 | $235,577.45 | -1.1% | -29.8% | -10.4% | |
| Jan 31, 2025 | Boyer David W.51 | Chief Corp. Affairs Officer | Sale+OE | 1,104 | $152.94 | $168,849.40 | -44.6% | -29.8% | -10.4% | |
| Jan 31, 2025 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 1,207 | $152.94 | $184,598.58 | -2.8% | -29.8% | -10.4% | |
| Jan 31, 2025 | Abernethy Matt57 | Chief Financial Officer | Sale+OE | 1,283 | $152.87 | $196,135.80 | -3.8% | -29.8% | -10.4% |